ArticleInvestigational new drugs2017

Safety of raltegravir-based antiretroviral therapy in HIV-infected patients receiving multi-kinase inhibitors.

Pierre Loulergue et al.PubMed ↗Publisher ↗

No numbers read from the abstract.